- Published at
- by financialpost.com
positive
positive
IntelGenx Obtains Preliminary Efficacy Results for the 'BUENA' Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer's Disease
MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) — IntelGenx Corp. (the “Company” or “IntelGenx” a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), ha…